917569-72-3 Usage
Derivative of pyrazole
The compound is based on a pyrazole ring, which is a five-membered heterocyclic compound with four carbon atoms and one nitrogen atom.
Bromine atom attached
The pyrazole ring has a bromine atom attached to the fourth position, which gives the compound unique properties.
Methylpropanoic acid group
The compound also contains a methylpropanoic acid group, which is a short-chain carboxylic acid.
Building block in synthesis
The compound is used as a building block in the synthesis of pharmaceuticals and agrochemicals, meaning it is a key component in creating more complex molecules.
Diverse biological activities
The compound is known for its diverse biological activities, meaning it can interact with various biological systems in different ways.
Potential use in treatment
The compound is being studied for its potential use in the treatment of various diseases, indicating that it may have therapeutic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 917569-72-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,5,6 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 917569-72:
(8*9)+(7*1)+(6*7)+(5*5)+(4*6)+(3*9)+(2*7)+(1*2)=213
213 % 10 = 3
So 917569-72-3 is a valid CAS Registry Number.
917569-72-3Relevant articles and documents
Manufacture of the PI3K β-Sparing Inhibitor Taselisib. Part 2: Development of a Highly Efficient and Regioselective Late-Stage Process
St-Jean, Frédéric,Remarchuk, Travis,Angelaud, Rémy,Carrera, Diane E.,Beaudry, Danial,Malhotra, Sushant,McClory, Andrew,Kumar, Archana,Ohlenbusch, Gerd,Schuster, Andreas M.,Gosselin, Francis
supporting information, p. 783 - 793 (2019/04/01)
A highly efficient and regioselective manufacturing route for the phosphoinositide 3-kinase β-sparing inhibitor taselisib was developed. Highlights of the synthesis include: (1) magnesium-mediated formation of a challenging cyclic amidine; (2) regioselect
